...
首页> 外文期刊>Clinical journal of the American Society of Nephrology: CJASN >Idiopathic IgA Nephropathy: Pathogenesis, Histopathology, and Therapeutic Options
【24h】

Idiopathic IgA Nephropathy: Pathogenesis, Histopathology, and Therapeutic Options

机译:特发性IgA肾病:发病机制,组织病理学和治疗选择

获取原文

摘要

IgA nephropathy is one of the most common causes of glomerulonephritis in the world. Proliferative and crescentic forms of IgA are found in up to 30% of cases and are associated with nephrotic-range proteinuria, accelerated hypertension, and accelerated decline toward ESRD. Despite its prevalence and clinical importance, there is no unifying nomenclature or consensus for the treatment of specific histologic subgroups. As a consequence, the development of clinically effective treatment regimens for IgA nephropathy have lagged behind other, less common forms of glomerulonephritis. Herein is reviewed the pathogenesis and histologic subtypes of IgA nephropathy and how conventional and immunosuppressive therapies have an impact on renal survival and recurrence rates. The use of known clinical risk factors for disease progression in conjunction with specific histologic features can be a guide to both induction and consolidation therapies for individual patients with IgA nephropathy.
机译:IgA肾病是世界上肾小球肾炎的最常见原因之一。 IgA的增生和新月形式在多达30%的病例中发现,并与肾病范围蛋白尿,高血压加速和ESRD加速下降有关。尽管其流行性和临床重要性,但尚无统一的命名法或共识来治疗特定的组织学亚组。结果,针对IgA肾病的临床有效治疗方案的发展已经落后于其他的,不太常见的肾小球肾炎。本文综述了IgA肾病的发病机制和组织学亚型,以及常规和免疫抑制疗法如何影响肾脏存活率和复发率。将已知的临床疾病危险因素与特定的组织学特征结合使用,可以为IgA肾病患者的诱导和巩固疗法提供指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号